4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-020187
Chief Regulatory Officer sold 3,530 shares at an average $4.11 ($14,509)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stevens Jennifer Chief Regulatory Officer | 2026-03-11 | Sale | −1,204 | $4.13 | $4,973 | 126,436 | D |
| Stevens Jennifer Chief Regulatory Officer | 2026-03-12 | Sale | −1,552 | $4.09 | $6,348 | 124,884 | D |
| Stevens Jennifer Chief Regulatory Officer | 2026-03-16 | Sale | −774 | $4.12 | $3,189 | 124,110 | D |
| Open-market sales · 3,530 sh · avg $4.11 · $14,509 | |||||||
Loading xslF345X06/wk-form4_1774038332.xml…